Intuitive Surgical, Inc. logo
Intuitive Surgical, Inc. (ISRG)
Compare

Intuitive Surgical, Inc. (ISRG) Stock Price: $426.61+8.00 (+1.91%)

The total return cagr for Intuitive Surgical, Inc. (ISRG) stock is -18.93% over the past 12 months. The 3 year average growth rate is 10.90% and the 5 year cagr is 8.78%. Total return includes dividends reinvested.

The closing share price for Intuitive Surgical, Inc. (ISRG) stock was $426.61 for Tuesday, June 9, 2026, up +1.91% from the previous day.

ISRG Price Chart

End-of-day pricesAdvanced chart →
ISRG$426.61 -19.45%as of Jun 9, 2026

ISRG Earnings Preview

Next Earnings Date

Jul 21, 2026

42 days away

EPS Estimate

2.50

Revenue Est.

$2.82B

Last Quarter Results

EPS

$2.50

vs Estimate

$2.11

Beat

Revenue

$2.77B

vs Estimate

$2.62B

Beat

ISRG Analyst Ratings

Consensus Rating

Buy

Based on 29 analysts

Strong Buy
6
Buy
16
Hold
9
Sell
1
Strong Sell
1

Average Price Target

$565.25

+32.5% upside

Low

$366.00

Current

$426.61

High

$750.00

ISRG Analyst Estimates

Forward P/E: 36.22

Earnings Per Share (EPS) Estimates

Quarterly

PeriodLowAvgHigh# Analysts
Q1 2027N/A$2.74N/A10
Q2 2027N/A$2.89N/A7
Q3 2027N/A$2.98N/A7
Q4 2027N/A$3.25N/A14

Annual

PeriodLowAvgHigh# Analysts
FY 2027N/A$11.78N/A18
FY 2028N/A$13.31N/A10

Revenue Estimates

Quarterly

PeriodLowAvgHigh# Analysts
Q1 2027N/A$3.12BN/A10
Q2 2027N/A$3.24BN/A7
Q3 2027N/A$3.31BN/A7
Q4 2027N/A$3.63BN/A14

Annual

PeriodLowAvgHigh# Analysts
FY 2027N/A$13.27BN/A18
FY 2028N/A$15.08BN/A10

Source: FMP Analyst Consensus Estimates. Forward P/E calculated using average EPS estimate for the nearest fiscal year.

ISRG Competitors' Key Metrics

StockMarket CapClose PricePrice ChangeTTM Total Return5Y CAGR10Y CAGR
1ISRG$151.09B$426.61+1.91%-18.93%+8.78%+19.47%

About Intuitive Surgical, Inc.

Intuitive Surgical, Inc. is a leading medical technology firm dedicated to advancing patient care by developing, producing, and commercializing sophisticated tools. These innovations empower medical professionals to deliver superior, accessible, and less-invasive treatment options to patients both within the United States and across international markets. Its flagship offering, the da Vinci Surgical System, facilitates intricate operations through a minimally disruptive approach. Expanding beyond surgical applications, the company also provides the Ion endoluminal system, designed for diagnostic interventions like minimally invasive lung biopsies. Complementing its primary systems, Intuitive Surgical supplies a comprehensive array of instruments, including stapling tools, energy devices, and essential core components. Furthermore, it offers structured training programs to ensure proficient use of its technology, alongside extensive customer support services encompassing installation, repairs, and ongoing maintenance. The firm also integrates digital capabilities to deliver unified, connected solutions that optimize hospital performance through actionable insights. Established in 1995, Intuitive Surgical maintains its corporate headquarters in Sunnyvale, California.

Sunnyvale, CA
15,638 employees
Healthcare / Medical - Devices
Sector
Healthcare
Industry
Medical - Devices
CEO
David J. Rosa